1. Home
  2. SWTX vs TEX Comparison

SWTX vs TEX Comparison

Compare SWTX & TEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • TEX
  • Stock Information
  • Founded
  • SWTX 2017
  • TEX 1933
  • Country
  • SWTX United States
  • TEX United States
  • Employees
  • SWTX N/A
  • TEX N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • TEX Construction/Ag Equipment/Trucks
  • Sector
  • SWTX Health Care
  • TEX Industrials
  • Exchange
  • SWTX Nasdaq
  • TEX Nasdaq
  • Market Cap
  • SWTX 3.5B
  • TEX 2.4B
  • IPO Year
  • SWTX 2019
  • TEX N/A
  • Fundamental
  • Price
  • SWTX $46.26
  • TEX $41.20
  • Analyst Decision
  • SWTX Buy
  • TEX Hold
  • Analyst Count
  • SWTX 7
  • TEX 11
  • Target Price
  • SWTX $56.86
  • TEX $46.40
  • AVG Volume (30 Days)
  • SWTX 8.7M
  • TEX 880.8K
  • Earning Date
  • SWTX 05-20-2025
  • TEX 05-02-2025
  • Dividend Yield
  • SWTX N/A
  • TEX 1.65%
  • EPS Growth
  • SWTX N/A
  • TEX N/A
  • EPS
  • SWTX N/A
  • TEX 3.67
  • Revenue
  • SWTX $191,589,000.00
  • TEX $5,064,000,000.00
  • Revenue This Year
  • SWTX $86.36
  • TEX $4.25
  • Revenue Next Year
  • SWTX $69.02
  • TEX $4.00
  • P/E Ratio
  • SWTX N/A
  • TEX $11.19
  • Revenue Growth
  • SWTX 3417.33
  • TEX N/A
  • 52 Week Low
  • SWTX $28.21
  • TEX $31.53
  • 52 Week High
  • SWTX $62.00
  • TEX $68.08
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 58.93
  • TEX 63.19
  • Support Level
  • SWTX $46.10
  • TEX $38.52
  • Resistance Level
  • SWTX $46.27
  • TEX $41.35
  • Average True Range (ATR)
  • SWTX 0.90
  • TEX 1.59
  • MACD
  • SWTX 0.58
  • TEX 0.80
  • Stochastic Oscillator
  • SWTX 99.46
  • TEX 95.45

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical-stage biopharmaceutical company applying a precision medicine approach to acquiring, developing, and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing prevalent, genetically defined cancers. OGSIVEO, the first commercial product, is a novel, oral, selective gamma-secretase inhibitor. GOMEKLI, the second commercial product, is an oral, small molecule mitogen-activated protein kinase, or MEK, inhibitor.

About TEX Terex Corporation

Terex Corp is a manufacturer of materials processing machinery, waste and recycling solutions, mobile elevating work platforms (MEWPs), and equipment for the electric utility industry. The company designs builds, and supports products used in maintenance, manufacturing, energy, waste and recycling, minerals and materials management, construction, and the entertainment industry. The products are manufactured in North America, Europe, and Asia Pacific and sold all over the world. The company reports business in the following segments: (i) Materials Processing, (ii) Aerial Work Platforms, and (iii) Environmental Solutions Group.

Share on Social Networks: